These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [A case report of uterine hemorrhage following the insertion of the Medusa intrauterine contraceptive device in the presence of uterine adenomyosis]. Cherveniashki S, Vasilev D. Akush Ginekol (Sofiia); 1990 Sep; 29(4):81-2. PubMed ID: 2267989 [No Abstract] [Full Text] [Related]
8. [Prostaglandin E2 receptor and uterine bleeding caused by intrauterine devices]. Zhu YP. Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):226-8, 254. PubMed ID: 2889584 [No Abstract] [Full Text] [Related]
9. [Complications of contraception with intra-uterine devices]. Gelpke W. Geburtshilfe Frauenheilkd; 1972 Oct; 32(10):908-9. PubMed ID: 4652288 [No Abstract] [Full Text] [Related]
14. [Use of oxytocics in the control of hemorrhages after the insertion of intrauterine devices]. Marques Mde M, Rodrigues W, Arkader J. Hospital (Rio J); 1970 Jul; 78(1):177-89. PubMed ID: 5312438 [No Abstract] [Full Text] [Related]
16. [Cytologic and histologic changes in the endometrium in users of intrauterine contraception having experienced bleeding]. Cirić B. Med Pregl; 1987 Jul; 40(3-4):159-61. PubMed ID: 3670225 [No Abstract] [Full Text] [Related]
18. [Risks of contraception using intrauterine devices]. Welti H. Ther Umsch; 1986 May; 43(5):400-3. PubMed ID: 3726776 [No Abstract] [Full Text] [Related]
19. [Results of bleeding prevention with fibrinolysis inhibitors in intrauterine contraception]. Tauber PF, Werling E, Klöppel A, Ludwig H. Arch Gynecol; 1979 Jul 20; 228(1-4):637-8. PubMed ID: 485529 [No Abstract] [Full Text] [Related]